Guillaume Lefèvre

机构：Centre National de la Recherche Scientifique, Inserm, ParisTech, Université de Lille, Université Paris Sciences et Lettres, Centre Hospitalier Universitaire de Lille, Center for Infection and Immunity of Lille, Institut de Recherche de Chimie Paris, Lille Inflammation Research International Center, Institute for Translational Research in Inflammation · ORCID：0000-0002-9427-7267

发表论文 397 篇 · 总被引 9631 次 · h-index 50

代表论文

• Inborn errors of immunity: Manifestation, treatment, and outcome—an ESID registry 1994–2024 report on 30,628 patients (2025 · Journal of Human Immunity · 被引 34)
• Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort (2025 · Allergy · 被引 21)
• Involvement of the JAK ‐ STAT pathway in the molecular landscape of tyrosine kinase fusion‐negative hypereosinophilic syndromes: A nationwide CEREO study (2024 · American Journal of Hematology · 被引 16)
• Recommendations for Transitioning Young People with Primary Immunodeficiency Disorders and Autoinflammatory Diseases to Adult Care (2024 · Journal of Clinical Immunology · 被引 9)
• Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins) (2025 · Orphanet Journal of Rare Diseases · 被引 8)
• Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials (2024 · EClinicalMedicine · 被引 8)